BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wang ZX, Wang EX, Bai W, Xia DD, Mu W, Li J, Yang QY, Huang M, Xu GH, Sun JH, Li HL, Zhao H, Wu JB, Yang SF, Li JP, Li ZX, Zhang CQ, Zhu XL, Zheng YB, Wang QH, Li J, Yuan J, Li XM, Niu J, Yin ZX, Xia JL, Fan DM, Han GH, on behalf of China HCC-TACE Study Group. Validation and evaluation of clinical prediction systems for first and repeated transarterial chemoembolization in unresectable hepatocellular carcinoma: A Chinese multicenter retrospective study. World J Gastroenterol 2020; 26(6): 657-669 [PMID: 32103874 DOI: 10.3748/wjg.v26.i6.657]
URL: https://www.wjgnet.com/1007-9327/full/v26/i6/657.htm
Number Citing Articles
1
Xavier Adhoute, Edouard Larrey, Rodolphe Anty, Patrick Chevallier, Guillaume Penaranda, Albert Tran, Jean-Pierre Bronowicki, Jean-Luc Raoul, Paul Castellani, Hervé Perrier, Olivier Bayle, Olivier Monnet, Bernard Pol, Marc Bourliere. Expected outcomes and patients’ selection before chemoembolization—“Six-and-Twelve or Pre-TACE-Predict” scores may help clinicians: Real-life French cohorts resultsWorld Journal of Clinical Cases 2021; 9(18): 4559-4572 doi: 10.12998/wjcc.v9.i18.4559
2
Apichat Kaewdech, Pimsiri Sripongpun, Natcha Cheewasereechon, Sawangpong Jandee, Naichaya Chamroonkul, Teerha Piratvisuth. Validation of the “Six-and-Twelve” Prognostic Score in Transarterial Chemoembolization–Treated Hepatocellular Carcinoma PatientsClinical and Translational Gastroenterology 2021; 12(2): e00310 doi: 10.14309/ctg.0000000000000310
3
Haifeng Zhou, Jianwu Ren, Feida Wu, Wei Yang, Di Zhu, Yuguan Xie, Qi Shi, Zhongling Pei, Yan Shen, Lingling Wu, Sheng Liu, Haibin Shi, Weizhong Zhou. Validation of the CRAFITY score for predicting prognosis in patients with hepatocellular carcinoma undergoing transarterial chemoembolization combined with systemic therapyJournal of Interventional Medicine 2024;  doi: 10.1016/j.jimed.2023.12.004
4
Xavier Adhoute, Guillaume Pénaranda, Jean-Luc Raoul, Jean-Pierre Bronowicki, Rodolphe Anty, Marc Bourlière. “Six-and-twelve” score for outcome prediction of hepatocellular carcinoma following transarterial chemoembolization. In-depth analysis from a multicenter French cohortWorld Journal of Hepatology 2020; 12(8): 525-532 doi: 10.4254/wjh.v12.i8.525
5
Zhuofan Deng, Wenfeng Zhang, Junwei Peng, Linxiao Gao, Chunyu Zhang, Kai Lei, Jianping Gong, Bin Xiong. Controlling Nutritional Status (CONUT) Score is Associated with Overall Survival in Patients with Hepatocellular Carcinoma Treated with Conventional Transcatheter Arterial Chemoembolization: A Propensity Score Matched AnalysisCardioVascular and Interventional Radiology 2024; 47(5): 592 doi: 10.1007/s00270-024-03712-1
6
Xiang-Ke Niu, Xiao-Feng He. A Nomogram Based on Preoperative Lipiodol Deposition after Sequential Retreatment with Transarterial Chemoembolization to Predict Prognoses for Intermediate-Stage Hepatocellular CarcinomaJournal of Personalized Medicine 2022; 12(9): 1375 doi: 10.3390/jpm12091375
7
Jun Deng, Wei Chen, Xiaoxia Wu, Yan Zhou, Jun Li. Evaluating the predictive power of circulating tumor cells for the prognosis of transarterial chemoembolization treatment on patients with advanced hepatocellular carcinomaMedicine 2021; 100(1): e24060 doi: 10.1097/MD.0000000000024060
8
Kefeng Jia, Weili Yin, Zhongsong Gao, Wen Shen, Fang Wang, Shuangshuang Xie, Mingge Li, Rong Lv. Recommendation of mHAP and ABCR scoring systems for the decision-making of the first and subsequent TACE session in HCC patientsEuropean Journal of Gastroenterology & Hepatology 2023; 35(4): 461 doi: 10.1097/MEG.0000000000002515